Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Leukemia

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 29 articles: HTML format

Single Articles

December 2022
1. CHENG WY, Li JF, Zhu YM, Lin XJ, et al
   Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia.
   Proc Natl Acad Sci U S A. 2022;119:e2211429119.
   PubMed     Abstract available
   
   
   October 2022
2. CHEN Q, Cevher MA, Jiang Q, Wang S, et al
   LYL1 facilitates AETFC assembly and gene activation by recruiting CARM1 in t(8;21) AML.
   Proc Natl Acad Sci U S A. 2022;119:e2213718119.
   PubMed     Abstract available
   
   
   September 2022
3. RAHMAN S, Hoffmann NA, Worden EJ, Smith ML, et al
   Multistate structures of the MLL1-WRAD complex bound to H2B-ubiquitinated nucleosome.
   Proc Natl Acad Sci U S A. 2022;119:e2205691119.
   PubMed     Abstract available
   
   
   August 2022
4. ARNOVITZ S, Mathur P, Tracy M, Mohsin A, et al
   Tcf-1 promotes genomic instability and T cell transformation in response to aberrant beta-catenin activation.
   Proc Natl Acad Sci U S A. 2022;119:e2201493119.
   PubMed     Abstract available
   
   
   July 2022
5. KOGAN AA, Topper MJ, Dellomo AJ, Stojanovic L, et al
   Activating STING1-dependent immune signaling in TP53 mutant and wild-type acute myeloid leukemia.
   Proc Natl Acad Sci U S A. 2022;119:e2123227119.
   PubMed     Abstract available
   
   
   
6. LAFFEY KG, Stiles RJ, Ludescher MJ, Davis TR, et al
   Early expression of mature alphabeta TCR in CD4(-)CD8(-) T cell progenitors enables MHC to drive development of T-ALL bearing NOTCH mutations.
   Proc Natl Acad Sci U S A. 2022;119:e2118529119.
   PubMed     Abstract available
   
   
   June 2022
7. MIYAKE A, Ngo MH, Wulandari S, Shimojima M, et al
   Convergent evolution of antiviral machinery derived from endogenous retrovirus truncated envelope genes in multiple species.
   Proc Natl Acad Sci U S A. 2022;119:e2114441119.
   PubMed     Abstract available
   
   
   
8. DONG H, Ham JD, Hu G, Xie G, et al
   Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia.
   Proc Natl Acad Sci U S A. 2022;119:e2122379119.
   PubMed     Abstract available
   
   
   April 2022
9. HOANG DH, Zhao D, Branciamore S, Maestrini D, et al
   MicroRNA networks in FLT3-ITD acute myeloid leukemia.
   Proc Natl Acad Sci U S A. 2022;119:e2112482119.
   PubMed     Abstract available
   
   
   
10. DAI YT, Zhang F, Fang H, Li JF, et al
    Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases.
    Proc Natl Acad Sci U S A. 2022;119:e2120787119.
    PubMed     Abstract available
    
    
    March 2022
11. CHAN LH, Yan Q
    Awakening KDM5B to defeat leukemia.
    Proc Natl Acad Sci U S A. 2022;119:e2202245119.
    PubMed    
    
    
    
12. REN Z, Kim A, Huang YT, Pi WC, et al
    A PRC2-Kdm5b axis sustains tumorigenicity of acute myeloid leukemia.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available
    
    
    January 2022
13. PEPE F, Rassenti LZ, Pekarsky Y, Labanowska J, et al
    A large fraction of trisomy 12, 17p(-), and 11q(-) CLL cases carry unidentified microdeletions of miR-15a/16-1.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available
    
    
    December 2021
14. GUO B, Pomicter AD, Li F, Bhatt S, et al
    Trident cold atmospheric plasma blocks three cancer survival pathways to overcome therapy resistance.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
15. FERRARO F, Miller CA, Christensen KA, Helton NM, et al
    Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    November 2021
16. LYCZEK A, Berger BT, Rangwala AM, Paung Y, et al
    Mutation in Abl kinase with altered drug-binding kinetics indicates a novel mechanism of imatinib resistance.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    October 2021
17. GARCIA-GARCIA A, Klein T, Born G, Hilpert M, et al
    Culturing patient-derived malignant hematopoietic stem cells in engineered and fully humanized 3D niches.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    August 2021
18. BENSBERG M, Rundquist O, Selimovic A, Lagerwall C, et al
    TET2 as a tumor suppressor and therapeutic target in T-cell acute lymphoblastic leukemia.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
19. YANG L, Yin J, Wu J, Qiao L, et al
    Engineering genetic devices for in vivo control of therapeutic T cell activity triggered by the dietary molecule resveratrol.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    July 2021
20. WU A, Zhi J, Tian T, Cihan A, et al
    DOT1L complex regulates transcriptional initiation in human erythroleukemic cells.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    June 2021
21. O'SULLIVAN D, Stanczak MA, Villa M, Uhl FM, et al
    Fever supports CD8(+) effector T cell responses by promoting mitochondrial translation.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
22. CHRETIEN AS, Devillier R, Granjeaud S, Cordier C, et al
    High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    April 2021
23. RIVERA OD, Mallory MJ, Quesnel-Vallieres M, Chatrikhi R, et al
    Alternative splicing redefines landscape of commonly mutated genes in acute myeloid leukemia.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    March 2021
24. KU Y, Park JH, Cho R, Lee Y, et al
    Noncanonical immune response to the inhibition of DNA methylation by Staufen1 via stabilization of endogenous retrovirus RNAs.
    Proc Natl Acad Sci U S A. 2021;118:e2016289118.
    PubMed     Abstract available
    
    
    
25. OWEN N, Minko IG, Moellmer SA, Cammann SK, et al
    Enhanced cytarabine-induced killing in OGG1-deficient acute myeloid leukemia cells.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
26. LOVAT F, Gasparini P, Nigita G, Larkin K, et al
    Loss of expression of both miR-15/16 loci in CML transition to blast crisis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    February 2021
27. WU K, Huynh KQ, Lu I, Moustakim M, et al
    Inhibitors of cullin-RING E3 ubiquitin ligase 4 with antitumor potential.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
28. PAN L, Hong C, Chan LN, Xiao G, et al
    PON2 subverts metabolic gatekeeper functions in B cells to promote leukemogenesis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
29. LEE YL, Ito K, Pi WC, Lin IH, et al
    Mediator subunit MED1 is required for E2A-PBX1-mediated oncogenic transcription and leukemic cell growth.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: